Literature DB >> 1482661

Molecular characterization of a novel 10.3 kb deletion causing beta-thalassaemia with unusually high Hb A2.

J E Craig1, S J Kelly, R Barnetson, S L Thein.   

Abstract

A family of Asian-Indian descent has a variant form of beta-thalassaemia characterized by unusually high levels of Hb A2 in the heterozygous state. The propositus who is homozygous for the mutation has thalassaemia intermedia. Restriction endonuclease mapping suggested the presence of a 10.3 kilobase (kb) deletion removing the whole of the beta-globin gene. Subsequently, molecular analysis was performed by directly sequencing a specifically amplified region of genomic DNA. A 10329 basepair deletion was precisely defined which results in the loss of the 5' beta promoter region and the entire beta-globin gene. The deletion extends from 3011 bp 5' to the mRNA cap site to an L1 repeat element downstream of the beta-globin gene and is very similar to the 12.6 kb deletion of Dutch beta zero-thalassaemia. In common with four other mutations, both these deletions remove the 5' promoter region of the beta gene and all are associated with unusually elevated levels of Hb A2 in the heterozygous state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482661     DOI: 10.1111/j.1365-2141.1992.tb06952.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  A novel deletion of β-globin promoter causing high HbA2 in an Indian population.

Authors:  Thiyagaraj Mayuranathan; Janakiram Rayabaram; Eunice Sindhuvi Edison; Alok Srivastava; Shaji R Velayudhan
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

2.  Roles of retrotransposons in benign and malignant hematologic disease.

Authors:  Anna M Schneider; Amy S Duffield; David E Symer; Kathleen H Burns
Journal:  Cellscience       Date:  2009-10-27

Review 3.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 4.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

5.  Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.

Authors:  Sarah K Topfer; Ruopeng Feng; Peng Huang; Lana C Ly; Gabriella E Martyn; Gerd A Blobel; Mitchell J Weiss; Kate G R Quinlan; Merlin Crossley
Journal:  Blood       Date:  2022-04-07       Impact factor: 22.113

Review 6.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

7.  Detection of α-thalassemia-1 Southeast Asian and Thai type deletions and β-thalassemia 3.5-kb deletion by single-tube multiplex real-time PCR with SYBR Green1 and high-resolution melting analysis.

Authors:  Sakorn Pornprasert; Thanatcha Wiengkum; Sarinee Srithep; Isarapong Chainoi; Panthong Singboottra; Sanchai Wongwiwatthananukit
Journal:  Korean J Lab Med       Date:  2011-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.